0001604710-17-000001.txt : 20170106 0001604710-17-000001.hdr.sgml : 20170106 20170106150352 ACCESSION NUMBER: 0001604710-17-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20170106 DATE AS OF CHANGE: 20170106 EFFECTIVENESS DATE: 20170106 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Transplant Genomics Inc. CENTRAL INDEX KEY: 0001604710 IRS NUMBER: 462380447 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-277845 FILM NUMBER: 17514033 BUSINESS ADDRESS: STREET 1: 1501 BEACON STREET STREET 2: #1903 CITY: BROOKLINE STATE: MA ZIP: 02446 BUSINESS PHONE: 617-733-0757 MAIL ADDRESS: STREET 1: 1501 BEACON STREET STREET 2: #1903 CITY: BROOKLINE STATE: MA ZIP: 02446 D 1 primary_doc.xml X0707 D LIVE 0001604710 Transplant Genomics Inc. 905 S Main Street Suite 202 Mansfield MA MASSACHUSETTS 02048 617-733-0757 DELAWARE None None Corporation true 2013 Stanley Rose c/o Transplant Genomics Inc. 905 S Main Street, Suite 202 Mansfield MA MASSACHUSETTS 02048 Executive Officer Director Michael Abecassis c/o Transplant Genomics Inc. 905 S Main Street, Suite 202 Mansfield MA MASSACHUSETTS 02048 Director Roy First c/o Transplant Genomics Inc. 905 S Main Street, Suite 202 Mansfield MA MASSACHUSETTS 02048 Executive Officer Darren Lee c/o Transplant Genomics Inc. 905 S Main Street, Suite 202 Mansfield MA MASSACHUSETTS 02048 Executive Officer Peter Lewis c/o Transplant Genomics Inc. 905 S Main Street, Suite 202 Mansfield MA MASSACHUSETTS 02048 Executive Officer Other Decline to Disclose 06b false 2016-12-22 false true true false 0 Arcadia Securities, LLC None Arcadia Securities, LLC 50764 304 Tom Hunter Road Fort Lee NJ NEW JERSEY 07024 NY NEW YORK false 3500000 1420921 2079079 false 22 0 19710 $9,854.61 of the $19,710 Finders' Fees indicated above is in the form of a convertible promissory note issued by Transplant Genomics Inc. 0 false Transplant Genomics Inc. /s/ Stanley Rose Stanley Rose CEO 2017-01-06